Harnessing Pharmacogenomics to Tackle Resistance to the “Nucleoside Reverse Trancripatse Inhibitor” Backbone of Highly Active Antiretroviral Therapy in Resource Limited Settings

BACKGROUND: The sustainable use of HAART within the sub-Saharan and other developing world settings faces the emerging challenge of drug resistance. Nucleoside reverse transcriptase inhibitors (NRTI) form the backbone of HAART and preserving their “antiviral efficacy” is thus critical to sustainable...

Descripción completa

Detalles Bibliográficos
Autores principales: Wayengera, Misaki, Kajumbula, Henry, Byarugaba, Wilson
Formato: Texto
Lenguaje:English
Publicado: Bentham Open 2008
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627514/
https://www.ncbi.nlm.nih.gov/pubmed/19274067
http://dx.doi.org/10.2174/1874613600802010078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627514/
https://www.ncbi.nlm.nih.gov/pubmed/19274067
http://dx.doi.org/10.2174/1874613600802010078

Ejemplares similares